Are Peptides Legal? The Status by Category

By Evan Marsh, EditorUpdated Sources: FDA compounding lists, import policy, WADA

The question has no single answer, and that is not evasion — it is the actual state of the law. "Peptide" describes a chemical structure, not a legal class. Semaglutide is a peptide and so is BPC-157; one is a prescription medicine with an approved label, the other cannot legally be sold for human use at all. Any page that answers "are peptides legal" with one word is answering a different question than the one you asked.

Four different legal positions

CategoryExamplesLegal position
FDA-approved medicinesSemaglutide, tirzepatide, tesamorelin, bremelanotide, elamipretidePrescription drugs. Legal to prescribe, dispense and use for their approved indications.
Formerly approved, discontinuedSermorelinUnusual position. Geref left the market in 2008 as a business decision, and FDA formally determined it was not withdrawn for safety or effectiveness — which is why compounding pharmacies prescribe it.
Research chemicalsRetatrutide, BPC-157, TB-500, CJC-1295Legal to sell labelled for laboratory research. Not legal to market for human use. No approval, no prescription route.
Subject to enforcementMelanotan IINever approved anywhere, and the subject of FDA warning letters and a permanent debarment order documented in the Federal Register.

What "research use only" actually means

It is a marketing designation, not a quality or safety statement. The label tells you what the seller is permitted to claim: that the product is for laboratory work, not for putting in a person. It carries no assurance that the vial contains what it says, that it was made under controlled conditions, or that anyone has evaluated it. No regulator inspects research-chemical manufacturing the way they inspect a drug plant.

The designation is what keeps the category lawful. A supplier who advertises dosing protocols for humans, publishes before-and-after photographs, or makes therapeutic claims has stepped outside it — which is why those signals appear in oursupplier evaluation guide as red flags. They indicate a vendor willing to ignore the rule that keeps them operating.

The compounding question

Compounding pharmacies can legally prepare medicines from bulk substances, but only from substances FDA permits. This is where much of the peptide legal picture is currently decided:

  • Category 2 — FDA's list of bulk drug substances that may present significant safety risks. Substances placed here are effectively closed to 503A compounding.
  • Nominated but withdrawn — a separate list where BPC-157, TB-500 and injectable GHK-Cu currently sit. This is widely misreported as FDA "clearing" them. It means the nomination was pulled, not that the agency reviewed and approved anything.
  • Retatrutide has no compounding route at all — it is not a component of any approved drug and does not appear on any permitted list. Unlike semaglutide during its shortage years, there is no legal compounded version.

Update · July 2026

An advisory committee voted to loosen the compounding rules

On 23–24 July 2026, FDA's Pharmacy Compounding Advisory Committee voted in favour of adding six peptides to the 503A bulk substances list — BPC-157, KPV and TB-500 each by 8–6, with MOTS-c, Semax and Epitalon following. FDA's own staff scientists had assessed the safety and effectiveness data as lacking.

Nothing changed legally on the day of the vote. Advisory votes are non-binding; FDA decides through formal rulemaking, a process measured in many months to years. Until a rule issues, these substances remain ineligible for compounding and unapproved for human use. Detail on the BPC-157 page.

Importing

FDA's personal importation policy is narrower than it is usually described. It is enforcement discretion, not a right, and it contemplates specific circumstances — typically a serious condition for which no approved treatment is available domestically, with the product not representing an unreasonable risk. Buying an unapproved research compound from abroad does not fit that description.

The practical consequence is that international shipments of unapproved drugs can be detained or refused entry at the border. This is a customs and product matter rather than a criminal one for a personal-quantity purchase, but the package can simply disappear, and the seller is rarely obliged to replace it.

Legal to buy, banned to use

These are entirely separate systems, and confusing them has ended careers. The WADA Prohibited List operates independently of drug approval:

WADA sectionCoversExamples
S0Non-approved substances — anything with no current regulatory approval for human therapeutic useBPC-157 (named explicitly in the 2026 List)
S2.2GHRH and its analoguesCJC-1295, sermorelin, tesamorelin
S2.3Growth factors, including thymosin-β4 derivativesTB-500

A compound being available for purchase says nothing about whether it is permitted for a tested athlete. S0 in particular is a catch-all: if a substance has no approval anywhere, it is prohibited at all times regardless of whether it appears by name.

State law and telehealth

Federal law is not the whole picture. States regulate pharmacy practice, and the rules governing what a compounding pharmacy may prepare and ship across state lines vary. The rapid growth of telehealth prescribing has outpaced settled guidance in several states, and a clinic operating lawfully in one may not be in another. If you are being prescribed a compounded peptide, the specific question worth asking is which pharmacy is preparing it and under what authority.

The short version

  • Approved medicines — legal with a prescription, for the approved indication.
  • Research chemicals — legal to sell for laboratory use, not legal to market for human use, no prescription pathway, no regulator checking the contents.
  • Buying — generally not prosecuted; imports carry seizure risk.
  • "Research use only" — a marketing category, not a quality standard.
  • Sport — a separate rulebook that bans much of what is legal to buy.
  • Outside the US — materially different, sometimes stricter. Several countries treat these as prescription-only medicines regardless of labelling.

Frequently asked questions

Are peptides legal in the United States?

It depends entirely on which peptide and what you do with it. Some are approved prescription medicines. Some are sold legally as research chemicals but cannot legally be marketed for human use. Some are prohibited from compounding. "Peptides" is not one legal category — it is a chemical description covering products with completely different legal statuses.

Is it illegal to buy research peptides?

Selling a compound labelled for laboratory research is generally lawful in the United States. Buying it is not typically prosecuted. What is unlawful is marketing it for human consumption, and imports of unapproved drugs can be detained or seized by customs. Nothing here is legal advice, and rules differ substantially between countries.

What does "research use only" actually mean legally?

It means the seller is not representing the product as a drug or supplement for human use, which keeps it outside the approval requirements that would otherwise apply. It is a statement about how the product may be marketed. It is not a quality standard, not a safety finding, and not permission to use the product in a person.

Can a doctor prescribe peptides?

Approved peptide medicines, yes — semaglutide, tirzepatide, tesamorelin and bremelanotide all have FDA approvals and prescription pathways. Unapproved compounds like retatrutide and BPC-157 have no prescription route, and cannot legally be compounded either.

Are peptides banned in sports?

Many are. The WADA Prohibited List bans growth hormone secretagogues and GHRH analogs under section S2, thymosin-β4 derivatives under S2.3, and catches unapproved substances such as BPC-157 under S0. A compound being legal to buy has no bearing on whether it will end an athletic career.

Sources

  • FDA. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks — the Category 2 table and the separate “nominated but withdrawn” list. FDA
  • FDA. Human Drug Imports — personal importation policy and its criteria. FDA · Personal Importation
  • FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA
  • FDA Pharmacy Compounding Advisory Committee, meeting of 23–24 July 2026. Meeting page · Briefing document (PDF)
  • FDA. Determination That GEREF (Sermorelin Acetate) Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register, 4 March 2013. Federal Register
  • FDA. Debarment order, 81 FR 79501–79502 (Melanotan II distribution). Federal Register
  • World Anti-Doping Agency. Prohibited List 2026. WADA Prohibited List

Related guides

Not legal advice. This page summarizes publicly available regulatory documents as of August 2026. Regulations change, state law varies, and other countries differ substantially. For a decision that matters, consult a qualified attorney.